Lisa French

Lisa French will serve as Chief Commercial Officer for the combined organization following the close of the transaction. Currently, Ms. French holds the role of Executive Vice President and Chief Commercial Officer at Mallinckrodt, a position she assumed in October 2022. Ms. French has executive responsibility for all commercial and market access activities for the company’s Specialty Brands products, as well as launch execution for assets in Mallinckrodt’s near-term development portfolio. She also serves on the company’s executive committee.

With more than 30 years of experience in U.S. commercialization strategy and operations across the therapeutic lifecycle, Ms. French brings extensive expertise in go-to-market planning and execution.

Prior to joining Mallinckrodt, Ms. French served as U.S. Business Unit Lead of the Women’s Health Franchise at Organon & Co., a global healthcare company, where she led the commercial team from January 2021 through September 2022. Her earlier tenure at Merck included a series of roles with increasing responsibility. Ms. French ultimately led all aspects of a multi-billion-dollar brand, drove commercial innovation, and oversaw multiple sales teams. Her leadership positions at Merck included Associate Vice President, U.S. Marketing Lead for the HPV Franchise (October 2019–January 2021) and Associate Vice President, U.S. Strategy and Commercial Model Innovation (January 2016–October 2019).

Ms. French holds a Bachelor of Science in Biology from West Chester University and completed the Emerging Leaders and Leadership & Strategy executive programs at Harvard Business School.